查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1650961

凝胶电泳的全球市场

Gel Electrophoresis
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球凝胶电泳市场规模将达到 25 亿美元

2024 年全球凝胶电泳市场规模估计为 19 亿美元，预计 2030 年将达到 25 亿美元，2024 年至 2030 年的复合年增长率为 5.3%。实验室研究最终用途是报告中分析的细分市场之一，预计复合年增长率为 5.3%，到分析期结束时将达到 12 亿美元。在分析期内，製药和生物技术最终用途部门的复合年增长率预计为 5.8%。

美国市场规模估计为 4.828 亿美元，中国市场预计复合年增长率为 8.2%

预计到 2024 年美国凝胶电泳市场价值将达到 4.828 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 5.752 亿美元，在 2024 年至 2030 年的分析期间内，复合年增长率为 8.2%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 3.1% 和 4.2%。在欧洲，德国的复合年增长率预计为 3.8%。

全球凝胶电泳市场-主要趋势与驱动因素摘要

为什么凝胶电泳对现代分子生物学和研究至关重要？

凝胶电泳是分子生物学和生物化学中的一项基本技术，在核酸（DNA、RNA）和蛋白质的分析和分离中起着重要作用。但为什么这项技术在现代科学研究中如此重要？凝胶电泳至关重要，因为它允许科学家根据分子的大小、电荷和形状分离分子，让他们能够精确地观察、量化和分析遗传物质和蛋白质。该技术广泛应用于从基因指纹识别和法医学分析到基因克隆、基因工程和蛋白质研究等各种应用领域。

在 DNA 分析中，凝胶电泳对于确认聚合酵素链锁反应(PCR) 和限制性酶消化的成功尤其重要，这是基因研究和分子克隆中必不可少的步骤。研究人员利用它来确认 DNA 片段的存在、大小和完整性，从而能够绘製基因图谱、研究基因突变或在法医学案件中识别个体。在蛋白质研究中，凝胶电泳有助于确定蛋白质的纯度、分子量和结构，这对于药物开发和诊断应用至关重要。由于其多功能性和精确度，凝胶电泳仍然是分子生物学研究的基石，推动了基因组学、蛋白质组学和个人化医疗的突破性进展。

科技进步如何增强凝胶电泳技术？

凝胶电泳技术的进步极大地提高了它的准确性、速度和易用性，使其成为分子生物学和生物化学研究的更强大的工具。一项重大技术创新是自动电泳系统的开发。这些系统将从样品加载到成像的所有电泳步骤集成为一个简化的自动化流程。自动化系统可减少人为错误，提供一致的结果，并允许同时分析多个样本，从而提高实验室的吞吐量和效率。

另一项重大进步是凝胶材料的改进。虽然传统的琼脂糖和聚丙烯酰胺凝胶仍被广泛使用，但正在开发具有更好解析度和更快运行时间的新型凝胶。例如，预製凝胶是预先製备的，这样研究人员就不必自己准备凝胶。预製凝胶的厚度和成分也更均匀，确保更准确和可重复的结果。此外，不同密度的梯度凝胶的开发使得同一样品中不同大小的分子能够更精确地分离，从而提高结果的透明度。

萤光染色技术是凝胶电泳的另一项突破。溴化乙锭等传统染色剂已被更安全、更灵敏的萤光染料所取代，能够检测出更少量的核酸和蛋白质。这些染料会与感兴趣的分子结合，并在特定波长的光照射下发出明亮的萤光讯号，从而可以轻鬆检测到微量的物质。这种灵敏度在次世代定序和蛋白质体学等需要准确定量的应用中尤其有价值。

此外，电泳缓衝液和温度控制系统等操作条件的进步有助于防止分离过程中敏感生物分子的劣化，进一步提高了凝胶电泳的可靠性。这些创新使得凝胶电泳更加强大、准确且易于使用，扩大了其在基因组学、蛋白质组学和分子诊断等前沿研究领域的应用。

为什么凝胶电泳对于研究和诊断 DNA、RNA 和蛋白质至关重要？

凝胶电泳对于 DNA、RNA 和蛋白质的分析至关重要，特别是在精确度和准确度至关重要的研究和诊断应用中。在 DNA 和 RNA 分析中，凝胶电泳可以依大小分离核酸。这对于 PCR 或限制性酶消化等技术后可视化遗传物质至关重要。透过这种分离，研究人员可以确认特定 DNA 或 RNA 片段的存在，评估其品质并确定其大小——这是基因图谱、克隆和序列测定的关键因素。在法医学中，凝胶电泳也用于 DNA 指纹识别，其中 DNA 片段的独特模式可用于识别个人或建立关係。

在蛋白质研究中，凝胶电泳对于分析蛋白质组成、结构和功能至关重要。 SDS-PAGE（十二烷基硫酸钠聚丙烯酰胺凝胶电泳）等技术可根据蛋白质的分子量分离蛋白质，使科学家能够研究复杂混合物中的单一蛋白质。这对于药物开发至关重要，研究人员需要分离和研究涉及疾病途径的特定蛋白质。凝胶电泳也用于评估蛋白质纯度和检测转译后修饰。这些对于生化研究和治疗药物开发非常重要。

此外，凝胶电泳在遗传疾病、癌症、感染疾病的诊断中也有重要作用。例如，它通常用于识别与囊肿纤维化和镰状细胞性贫血等疾病相关的基因突变。透过分离和分析患者样本中的 DNA 和 RNA，临床医生可以精确定位特定的基因异常，从而做出准确的诊断和个人化的治疗方案。此外，基于电泳的技术（例如西方印渍术）也用于临床诊断，以检测与疾病相关的蛋白质，例如自体免疫疾病中的抗体和爱滋病毒等感染疾病中的病毒蛋白。

摘要，它是一种在研究和诊断领域提供高精度分离和分析生物分子能力的基本工具。它在处理核酸和蛋白质方面的多功能性和有效性使其成为增进我们对遗传学、疾病机制和药物开发的理解的关键技术。

哪些因素推动了凝胶电泳市场的成长？

由于对分子诊断的需求不断增加、基因组研究的进步以及对更高效和精确的测试技术的需求，凝胶电泳市场正在经历强劲增长。其中一个主要驱动因素是基因组学和蛋白​​质组学领域的扩展，它们广泛使用电泳法分析 DNA、RNA 和蛋白质。随着研究人员对基因表现研究、基因图谱和个人化医疗的深入研究，对凝胶电泳等可靠、准确的技术的需求持续增长。

其次，对分子诊断的不断增长的需求正在推动市场成长。随着遗传疾病、癌症和感染疾病变得越来越普遍，医疗保健提供者正在转向分子诊断技术来准确识别和治疗这些疾病。凝胶电泳通常用于诊断，以检测基因突变、识别传染源和监测疾病进展。随着精准医疗成为医疗保健领域的标准方法，对精确的 DNA、RNA 和蛋白质分析的需求推动了电泳技术在临床环境中的应用。

第三，电泳系统的技术进步使得该技术更容易取得、更快捷、更易于使用。自动化凝胶电泳系统、预製凝胶和先进的成像技术降低了传统电泳过程的复杂性和所需的时间，鼓励更多的研究人员和临床医生采用这项技术。这些创新也提高了结果的准确性和可重复性，这对于诊断、药物开发和研究应用至关重要。

此外，对个人化医疗和生物标记发现的日益关注也促进了凝胶电泳市场的成长。当研究人员寻求识别与疾病相关的特定遗传标记或蛋白质特征时，凝胶电泳仍然是分离和可视化这些生物分子的关键技术。例如，在癌症研究中，电泳用于研究蛋白质表现模式和识别潜在的治疗目标，从而推动了对先进电泳系统的需求。

此外，政府对生命科学研究的资助和投资也进一步推动了市场成长。许多国家都在其医疗保健和研究倡议中大力投资基因组研究和分子诊断，从而导致学术、临床和製药实验室越来越多地采用凝胶电泳技术。

总之，由于对分子研究的需求不断增加、诊断技术的进步、个人化医疗的需求以及更快、更有效率的电泳系统的发展，凝胶电泳市场正在成长。随着这些趋势的持续，凝胶电泳将继续成为研究和临床实验室的基石技术，并将在促进我们对分子生物学的理解和改善医疗保健结果方面发挥关键作用。

部分

最终用户（实验室研究、製药和生物技术公司以及其他最终用户）

受访企业范例（共41家）

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • CBS Scientific Company
  • GE Healthcare
  • Harvard Bioscience, Inc.
  • Helena Laboratories Corporation
  • Hoefer, Inc.
  • Lonza Group AG
  • MilliporeSigma
  • PerkinElmer, Inc.
  • SCIEX
  • Sebia SA
  • SERVA Electrophoresis GmbH
  • Shimadzu Corporation
  • Sysmex Partec GmbH
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP12153

Global Gel Electrophoresis Market to Reach US$2.5 Billion by 2030

The global market for Gel Electrophoresis estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Laboratory Research End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Pharma & Biotech Companies End-Use segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$482.8 Million While China is Forecast to Grow at 8.2% CAGR

The Gel Electrophoresis market in the U.S. is estimated at US$482.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$575.2 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Gel Electrophoresis Market - Key Trends and Drivers Summarized

Why Is Gel Electrophoresis Critical in Modern Molecular Biology and Research?

Gel electrophoresis is a fundamental technique in molecular biology and biochemistry, playing a vital role in the analysis and separation of nucleic acids (DNA, RNA) and proteins. But why is this technique so crucial in modern scientific research? Gel electrophoresis is essential because it allows scientists to separate molecules based on their size, charge, or shape, making it possible to visualize, quantify, and analyze genetic material and proteins with precision. This technique is widely used in a range of applications, from genetic fingerprinting and forensic analysis to gene cloning, genetic engineering, and protein research.

In DNA analysis, gel electrophoresis is particularly important for verifying the success of polymerase chain reactions (PCR) or restriction enzyme digestion, which are essential steps in genetic studies and molecular cloning. Researchers use it to confirm the presence, size, and integrity of DNA fragments, enabling them to map genes, study genetic mutations, or even identify individuals in forensic cases. In protein studies, gel electrophoresis helps in determining the purity, molecular weight, and structure of proteins, making it indispensable for drug development and diagnostic applications. Given its versatility and precision, gel electrophoresis remains a cornerstone of molecular biology research, enabling breakthroughs in genomics, proteomics, and personalized medicine.

How Are Technological Advancements Enhancing Gel Electrophoresis?

Technological advancements in gel electrophoresis are significantly improving its precision, speed, and ease of use, making it an even more powerful tool for molecular and biochemical research. One of the key innovations is the development of automated electrophoresis systems. These systems integrate all the steps of electrophoresis—from sample loading to imaging—into a streamlined, automated process. Automated systems reduce human error, provide consistent results, and allow researchers to analyze multiple samples simultaneously, improving throughput and efficiency in laboratories.

Another major advancement is the improvement in gel materials. Traditional agarose and polyacrylamide gels are still widely used, but newer gels have been developed with better resolution and faster run times. For example, precast gels come pre-prepared, eliminating the need for researchers to prepare their own gels, which can be time-consuming and error-prone. Precast gels also offer more uniformity in thickness and composition, ensuring more accurate and reproducible results. Additionally, the development of gradient gels, which vary in density, allows for more precise separation of molecules of different sizes in the same sample, improving the clarity of results.

Fluorescent staining techniques represent another breakthrough in gel electrophoresis. Traditional stains like ethidium bromide have been largely replaced by safer and more sensitive fluorescent dyes that can detect much smaller quantities of nucleic acids and proteins. These dyes bind to the molecules of interest and, when exposed to specific wavelengths of light, produce a bright fluorescent signal, making it easier to detect even trace amounts of material. This sensitivity is particularly valuable in applications like next-generation sequencing or proteomics, where precise quantification is essential.

Additionally, advancements in electrophoresis buffers and running conditions, such as temperature-controlled systems, help prevent the degradation of sensitive biomolecules during the separation process, further improving the reliability of gel electrophoresis. These technological innovations are making gel electrophoresis more robust, accurate, and user-friendly, expanding its use in cutting-edge research fields such as genomics, proteomics, and molecular diagnostics.

Why Is Gel Electrophoresis Essential for DNA, RNA, and Protein Analysis in Research and Diagnostics?

Gel electrophoresis is indispensable for the analysis of DNA, RNA, and proteins, particularly in research and diagnostic settings where precision and accuracy are paramount. For DNA and RNA analysis, gel electrophoresis allows scientists to separate nucleic acids by size, which is crucial for visualizing genetic material after techniques like PCR or restriction enzyme digestion. This separation helps researchers confirm the presence of specific DNA or RNA fragments, assess their quality, and determine their size—key factors in gene mapping, cloning, and sequencing. In forensic science, gel electrophoresis is also used for DNA fingerprinting, where the unique patterns of DNA fragments can be used to identify individuals or verify relationships.

In protein research, gel electrophoresis is essential for analyzing protein composition, structure, and function. Techniques like SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis) allow proteins to be separated based on their molecular weight, enabling scientists to study individual proteins in complex mixtures. This is critical for drug development, where researchers need to isolate and study specific proteins involved in disease pathways. Gel electrophoresis is also used to assess protein purity and to detect post-translational modifications, both of which are important in biochemical research and the development of therapeutics.

Moreover, gel electrophoresis plays a vital role in diagnosing genetic disorders, cancers, and infections. For example, it is commonly used to identify mutations in genes that are linked to diseases like cystic fibrosis or sickle cell anemia. By separating and analyzing DNA or RNA from patient samples, clinicians can pinpoint specific genetic abnormalities, allowing for accurate diagnosis and personalized treatment plans. Additionally, electrophoresis-based techniques like Western blotting are used in clinical diagnostics to detect proteins associated with diseases, such as antibodies in autoimmune disorders or viral proteins in infections like HIV.

In summary, gel electrophoresis is a fundamental tool in both research and diagnostics, providing the ability to separate and analyze biological molecules with a high degree of precision. Its versatility and effectiveness in handling nucleic acids and proteins make it a critical technique for advancing our understanding of genetics, disease mechanisms, and drug development.

What Factors Are Driving the Growth of the Gel Electrophoresis Market?

The gel electrophoresis market is experiencing strong growth, driven by a combination of increasing demand for molecular diagnostics, advancements in genomic research, and the need for more efficient and precise laboratory techniques. One of the primary drivers is the expanding field of genomics and proteomics, which relies heavily on electrophoresis for DNA, RNA, and protein analysis. As researchers delve deeper into gene expression studies, genetic mapping, and personalized medicine, the demand for reliable and accurate techniques like gel electrophoresis continues to rise.

Second, the growing need for molecular diagnostics is fueling market growth. With the increasing prevalence of genetic disorders, cancers, and infectious diseases, healthcare providers are turning to molecular diagnostic techniques to accurately identify and treat these conditions. Gel electrophoresis is commonly used in diagnostics to detect genetic mutations, identify infectious agents, and monitor the progression of diseases. As precision medicine becomes a standard approach in healthcare, the need for accurate DNA, RNA, and protein analysis is driving the adoption of electrophoresis technologies in clinical settings.

Third, technological advancements in electrophoresis systems are making the technique more accessible, faster, and easier to use. Automated gel electrophoresis systems, pre-cast gels, and advanced imaging techniques are reducing the complexity and time required for traditional electrophoresis processes, attracting more researchers and clinicians to adopt this technology. These innovations are also improving the accuracy and reproducibility of results, which is essential for applications in diagnostics, drug development, and research.

Additionally, the increasing focus on personalized medicine and biomarker discovery is contributing to the growth of the gel electrophoresis market. As researchers seek to identify specific genetic markers or protein signatures linked to diseases, gel electrophoresis remains a key technique for separating and visualizing these biomolecules. In cancer research, for example, electrophoresis is used to study protein expression patterns and identify potential therapeutic targets, driving the demand for advanced electrophoresis systems.

Moreover, government funding and investments in life science research are further propelling market growth. Many countries are investing heavily in genomics research and molecular diagnostics as part of their healthcare and research initiatives, leading to greater adoption of gel electrophoresis technologies in academic, clinical, and pharmaceutical laboratories.

In conclusion, the gel electrophoresis market is growing due to the rising demand for molecular research, advancements in diagnostic technologies, the need for personalized medicine, and the development of faster, more efficient electrophoresis systems. As these trends continue, gel electrophoresis will remain a cornerstone technique in both research and clinical laboratories, playing a critical role in advancing our understanding of molecular biology and improving healthcare outcomes.

SCOPE OF STUDY:

The report analyzes the Gel Electrophoresis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Laboratory Research, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • C.B.S. Scientific Company
  • GE Healthcare
  • Harvard Bioscience, Inc.
  • Helena Laboratories Corporation
  • Hoefer, Inc.
  • Lonza Group AG
  • MilliporeSigma
  • PerkinElmer, Inc.
  • SCIEX
  • Sebia SA
  • SERVA Electrophoresis GmbH
  • Shimadzu Corporation
  • Sysmex Partec GmbH
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Gel Electrophoresis - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Use of Gel Electrophoresis in Genomics and Proteomics Drives Market Growth
    • Role of Gel Electrophoresis in Drug Discovery and Development Processes
    • Market Opportunities in Emerging Biotechnology Markets
    • Consumer Demand for Faster, More Accurate Diagnostic Techniques
    • Advances in Microfluidics and Miniaturization of Electrophoresis Equipment
    • Environmental and Safety Considerations in Electrophoresis Media Disposal
    • Role of Gel Electrophoresis in Quality Control in Food and Beverage Industry
    • Future Trends: Towards Chip-based Electrophoresis and Lab-on-a-Chip Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gel Electrophoresis Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Laboratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Laboratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Laboratory Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Gel Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Gel Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Gel Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION